Reviva Pharmaceuticals Holdings annual working capital
2019
2020
2022
2023
2024
2025
Reviva Pharmaceuticals Holdings Working Capital Growth & History (RVPH)
Reviva Pharmaceuticals Holdings's working capital was $7.8M for fiscal 2025.
View full Reviva Pharmaceuticals Holdings company overviewReviva Pharmaceuticals Holdings annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.8M | $7.7M | +9462.46% |
| 2024 | 2024-12-31 | $81,861 | −$6.4M | −98.75% |
| 2023 | 2023-12-31 | $6.5M | −$2.4M | −27.19% |
| 2022 | 2022-12-31 | $9.0M | — | — |
| 2020 · Feb 29 | 2020-02-29 | −$160,793 | −$541,922 | — |
| 2019 · Feb 28 | 2019-02-28 | $381,129 | — | — |
Reviva Pharmaceuticals Holdings quarterly working capital
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $15.2M | $16.5M | — |
| Q1 2026 | 2026-03-31 | $17.4M | $22.7M | — |
| Q4 2025 | 2025-12-31 | $7.8M | $7.7M | +9462.46% |
| Q3 2025 | 2025-09-30 | $3.8M | $14.5M | — |
| Q2 2025 | 2025-06-30 | −$1.3M | $5.4M | — |
| Q1 2025 | 2025-03-31 | −$5.3M | — | — |
| Q4 2024 | 2024-12-31 | $81,861 | −$6.4M | −98.75% |
| Q3 2024 | 2024-09-30 | −$10.7M | — | — |
| Q2 2024 | 2024-06-30 | −$6.7M | — | — |
| Q4 2023 | 2023-12-31 | $6.5M | — | — |
| Q3 2021 · Nov 30 | 2020-11-30 | −$815,589 | −$865,451 | — |
| Q2 2021 · Aug 31 | 2020-08-31 | −$698,330 | −$914,214 | — |
| Q1 2021 · May 31 | 2020-05-31 | −$261,570 | −$571,564 | — |
| Q4 2020 · Feb 29 | 2020-02-29 | −$160,793 | −$541,922 | — |
| Q3 2020 | 2019-11-30 | $49,862 | −$389,241 | −88.64% |
| Q2 2020 | 2019-08-31 | $215,884 | −$302,365 | −58.34% |
| Q1 2020 | 2019-05-31 | $309,994 | — | — |
| Q4 2019 · Feb 28 | 2019-02-28 | $381,129 | — | — |
| Q3 2019 | 2018-11-30 | $439,103 | — | — |
| Q2 2019 | 2018-08-31 | $518,249 | — | — |
Reviva Pharmaceuticals Holdings working capital trends
Between the periods ended 2019-02-28 and 2025-12-31, Reviva Pharmaceuticals Holdings's working capital increased from $381,129 to $7.8M, a change of $7.4M. The latest reported quarter, Q2 2026, shows $15.2M.
About the metric
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
Calculation and source
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Reviva Pharmaceuticals Holdings source filings ↗